Frequently Asked Questions
The Point of Care Diagnostics Market size will be worth USD 71,424.23 million during the forecast period.
The Point of Care Diagnostics Market growth rate is 9.1% during the forecast period.
The Rising Demand for Instantaneous Results, Technological Advancements in Diagnostics and Increasing Prevalence of Infectious Diseases are the growth drivers of the Point of Care Diagnostics Market.
The platform, prescription, end-user, and product are the factors on which the Point of Care Diagnostics Market research is based.
The major companies in the Point of Care Diagnostics Market are Abbott(U.S.), Siemens Healthineers AG (Germany), Quidel Corporation (U.S.), F. Hoffman-La Roche Ltd. (Switzerland), Danaher Corporation (U.S.), Becton, Dickinson and Company (U.S.), Chembio Diagnostics (U.S.), EKF Diagnostics (U.K.), Trinity Biotech plc (Ireland), Instrumentation Laboratory (a Werfen Company) (U.S.), Nova Biomedical (U.S.), PTS Diagnostics (U.S.), Sekisui Diagnostics (U.S.), Thermo Fisher Scientific (U.S.), bioMérieux S.A. (France).
